Read E.V.I.dently Today for current news about health policy and events, among other topics.
E.V.I.dently Today Blog
In a recent column for PharmaBoardroom, Michael Ciarametaro, vice president for research at the National Pharmaceutical Council, elaborated on the ways in which MBP presents a barrier to creative payment methodologies in the United States.
NPC's Dr. Dubois discusses a Health Affairs article identifying public health efforts and pharmaceuticals as leading drivers impacting increased life expectancy in the U.S. between 1990 and 2015.
As the interim leader of NPC, Dr. Robert Dubois, MD, PhD, plans to focus on two critical priorities. First, building on the great work and success that NPC achieved during Dan Leonard's 12 years of leadership by leveraging NPC's tradition of evidence-based research, partnership, and education. Second, preparing NPC for the future, anticipating some of the key issues we will face in the next year, or the next five years, or the next decade.
In an interview, Innovation and Value Initiative Executive Director Jennifer Bright discusses how her organization has been advancing value assessment practice and the key priorities to make the practice more meaningful, especially for patients
A summary with video clips from the robust discussion about the societal value and pricing of potential COVID-19 treatments and incentives for current and post-pandemic medical innovation.
In this Q&A, Randy Rutta, AARDA’s President and CEO, talks about his organization’s efforts to raise awareness about step therapy and opportunities for patient-centered reforms.